Sichuan Kelun-Biotech Inks Oncology Partnership with Crescent Biopharma

Sichuan Kelun-Biotech Biopharmaceutical has signed an oncology partnership with Crescent Biopharma, leading to a 3% rise in shares. The China-based company focuses on research and development, production, and sales of drugs, primarily in oncology, immunology, and other therapeutic fields. Its products include antibody-drug conjugates SKB264 and A166, used for treating breast cancer, non-small cell lung cancer, and gastrointestinal cancer.